Biocept, Inc. filed a voluntary petition liquidation under Chapter 7 in the US Bankruptcy Court for the District of Delaware on October 13, 2023. The debtor listed its assets of $2.49 million and liabilities of $2.92 million. The debtor is represented by Matthew P. Ward of Womble Bond Dickinson (US) LLP as its legal counsel.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0002 USD | +100.00% | +100.00% | -99.52% |
Apr. 26 | Motion for Asset Sale Approved for Biocept, Inc. | CI |
Apr. 02 | Motion for Asset Sale Approved for Biocept, Inc. | CI |
1st Jan change | Capi. | |
---|---|---|
-99.52% | 525 | |
-9.74% | 11.58B | |
-9.80% | 8.21B | |
+5.08% | 5.77B | |
+27.89% | 5.55B | |
-15.47% | 3.83B | |
+8.47% | 2.65B | |
-64.17% | 2.36B | |
-9.24% | 2.27B | |
+20.38% | 2.11B |
- Stock Market
- Equities
- BIOCQ Stock
- News Biocept, Inc.
- Biocept, Inc. Filed for Bankruptcy